STAT1 and neoplasm: Through the p50 NF-κB signaling pathway, tumor-derived PGE2 facilitates the binding of STAT1 to the regulatory regions of IFNγ-dependent genes, such as inducible nitric oxide synthase (Nos2), thereby promoting NO production and contributing to immune suppression [25].